[Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?].
Service d'Endocrinologie, Diabétologie et Maladies Métaboliques, Laboratoire de Recherche PCIM, Université Qadi Ayyad, CHU Mohamed VI, Marrakech, Maroc.
Hind
H
El Aassri
Service d'Endocrinologie, Diabétologie et Maladies Métaboliques, Laboratoire de Recherche PCIM, Université Qadi Ayyad, CHU Mohamed VI, Marrakech, Maroc.
Ghizlane
G
El Mghari
Service d'Endocrinologie, Diabétologie et Maladies Métaboliques, Laboratoire de Recherche PCIM, Université Qadi Ayyad, CHU Mohamed VI, Marrakech, Maroc.
Nawal
N
El Ansari
D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D019338:Polypharmacy; D011446:Prospective Studies
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents
HT; antihypertensive drugs; diabetes; insulinotherapy; oral antidiabetic; treatment adherence